28.10.2014 Views

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

41<br />

1<br />

SESSION FOUR ONE<br />

ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY<br />

Session 4: Lung Injury / Inflammation<br />

ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY<br />

SESSION<br />

4SESSION FOUR ONE<br />

4.1<br />

Hypercapnia does not attenuate oxidation in <strong>the</strong> endotoxin<br />

induced acute lung injury<br />

Introduction<br />

Acute Lung Injury (ALI) is a major problem<br />

causing thousands <strong>of</strong> deaths annually worldwide.<br />

Hypercapnic acidosis (HCA) has protective effects in<br />

endotoxin-induced ALI and may have <strong>the</strong>rapeutic<br />

potential. The mechanism <strong>of</strong> this protective action is<br />

unknown; it has been shown in vitro that high CO2<br />

can inhibit peroxynitrite-mediated oxidation, an<br />

important mechanism <strong>of</strong> damage in ALI. We tested<br />

<strong>the</strong> hypo<strong>the</strong>sis that HCA attenuates ALI in vivo by<br />

inhibiting peroxynitrite-mediated oxidation.<br />

Methods<br />

Adult rats were anaes<strong>the</strong>tized, mechanically<br />

ventilated and ALI induced by intra-tracheal<br />

instillation <strong>of</strong> endotoxin. We measured <strong>the</strong> oxidative<br />

<br />

formation <strong>of</strong> rhodamine from dihydrorhodamine in<br />

bronchoalveolar fluid (BAL). NOS inhibition<br />

(L-NMMA) was used to prevent peroxynitrite<br />

formation.<br />

Results<br />

The formation <strong>of</strong> rhodamine was increased above<br />

controls following endotoxin injury, however <strong>the</strong>re<br />

was no difference between <strong>the</strong> endotoxin groups<br />

(n=10 per group).<br />

Conclusions<br />

Oxidation was not inhibited by HCA in endotoxininduced<br />

ALI. The failure <strong>of</strong> NOS inhibition to reduce<br />

rhodamine formation, suggests that peroxynitrite<br />

was not an essential mediator <strong>of</strong> oxidation.<br />

<br />

<br />

A Nichol, D O’Croinin,<br />

F Naughton,<br />

P McLoughlin<br />

University College<br />

Dublin, School <strong>of</strong><br />

Medicine and Medical<br />

Sciences<br />

Supported by<br />

ICSI, IRCSET<br />

4.2<br />

Up-regulation <strong>of</strong> matrix metalloproteases and ca<strong>the</strong>psins<br />

by neutrophile elastase: a novel hierarchy in protease<br />

regulation<br />

Introduction<br />

Matrix metalloprotease (MMP), ca<strong>the</strong>psin and<br />

neutrophil elastase (NE) activities were measured in<br />

bronchoalveolar lavage (BAL) from individuals with<br />

Alpha-1 Antitrypsin (AAT) deficiency, pneumonia<br />

and healthy controls. We observed correlation<br />

between NE activity and ca<strong>the</strong>psin and MMP activity<br />

postulating that NE might upregulate expression <strong>of</strong><br />

<strong>the</strong>se key proteases and that this upregulation could<br />

be inhibited by treatment with aerosolised plasma<br />

purified AAT (ppAAT).<br />

Methods<br />

Macrophage supernatants were assessed for<br />

ca<strong>the</strong>psin and MMP expression and activity<br />

following stimulation with NE. Ca<strong>the</strong>psin and MMP<br />

activities were assessed in pneumonia and control<br />

BAL and in BAL from AAT deficient patients pre- and<br />

post- aerosolisation <strong>of</strong> ppAAT.<br />

Results<br />

Ca<strong>the</strong>psin and MMP activity are significantly higher<br />

in BAL samples in AAT deficiency and pneumonia<br />

compared to controls and correlate significantly<br />

with NE activity. Treatment with ppAAT significantly<br />

decreases ca<strong>the</strong>psin and MMP activity and<br />

expression in BAL from AAT deficient patients in vivo<br />

and pneumonia patients in vitro.<br />

Conclusions<br />

We describe a novel protease cascade whereby<br />

NE upregulates ca<strong>the</strong>psin and MMP expression/<br />

activation. Neutralization <strong>of</strong> NE by <strong>the</strong> antiprotease,<br />

AAT, inhibits this up-regulation. This<br />

new insight into protease function may facilitate<br />

targeted anti-protease <strong>the</strong>rapy in diseases such as<br />

COPD, CF, pneumonia and A1AT deficiency where NEinduced<br />

ca<strong>the</strong>psin / MMP-mediated inflammation<br />

are a feature.<br />

M Rogan, P Geraghty,<br />

C Greene, M Brantly,<br />

C Taggart, S O’Neill,<br />

NG McElvaney<br />

Pulmonary research<br />

Division, RCSI,<br />

Beaumont Hospital,<br />

Dublin and Dept <strong>of</strong><br />

Medicine, University <strong>of</strong><br />

Florida, USA<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

4.3<br />

Endoplasmic reticulum stress-induced apoptosis and<br />

its inhibition by Tauroursodeoxycholic acid in Alpha-1<br />

antitryspsin deficiency<br />

BAL NEUTROPHIL [*103/ML] PAO2[MMHG] RHODAMINE [PM]<br />

Control 9.1 (2.5) 136.4 (7.5) 23.3 (5.1)<br />

Normocapnia 5230* (991) 89.1* (6.0) 55.1* (4.8)<br />

Hypercapnia 5142* (1079) 105.4* (6.4) 48.7* (5.1)<br />

Normocapnia LNMMA 6065* (828) 103.3* (5.0) 46.4* (4.5)<br />

Hypercapnia LNMMA 5204* (1602) 92.4* (92.4) 52.9* (4.0)<br />

Values are mean (SEM). * significantly different from control [ANOVA]..<br />

<br />

Introduction<br />

Z alpha-1-antitrypsin (AAT) deficiency is a<br />

genetic disease associated with accumulation<br />

<strong>of</strong> misfolded AAT in <strong>the</strong> endoplasmic reticulum<br />

(ER). We investigated both <strong>the</strong> effect <strong>of</strong> ZAAT on<br />

apoptosis, using an in vitro model system <strong>of</strong> ZAAT ER<br />

accumulation, and <strong>the</strong> mechanism <strong>of</strong> inhibition <strong>of</strong><br />

this apoptosis by tauroursodeoxycholic acid (TUDCA).<br />

Method<br />

Apoptosis was induced in HEK293 cells using<br />

thapsigargin, etoposide or by transfection with<br />

a ZAAT cDNA. Cleavage <strong>of</strong> caspases-3,-4 and -7,<br />

cytochrome c release and phosphorylation <strong>of</strong> <strong>the</strong><br />

Bcl-2 family member Bad were assessed by western<br />

immunoblotting. Caspase activities were quantified<br />

by fluorimetry or luminometry, as appropriate.<br />

Apoptosis was demonstrated using TUNEL staining<br />

and cell viability assays were performed. The<br />

inhibitory effects <strong>of</strong> TUDCA were also assessed.<br />

Results<br />

ER accumulation <strong>of</strong> ZAAT, but not normal MAAT,<br />

leads to cleavage and activation <strong>of</strong> caspases -3,-4<br />

and -7. Similar effects were also induced using <strong>the</strong><br />

ER agonist thapsigargin. TUNEL staining <strong>of</strong> ZAATexpressing<br />

cells confirmed <strong>the</strong> presence <strong>of</strong> apoptosis.<br />

Inhibition studies using TUDCA demonstrated its<br />

ability to inhibit caspase-4 and caspase-3/7 activation,<br />

mitochondrial release <strong>of</strong> cytochrome c and apoptosis<br />

induced by ZAAT. TUDCA increased phosphorylation<br />

<strong>of</strong> Bad. Cell viability assays confirmed <strong>the</strong> beneficial<br />

effect <strong>of</strong> TUDCA on cell survival.<br />

Conclusions<br />

Our data shows a new mechanism <strong>of</strong> cell death<br />

in ZAAT deficiency: Activation <strong>of</strong> <strong>the</strong> caspase<br />

cascade and apoptosis via <strong>the</strong> ER-specific caspase-<br />

4. Inhibition studies using TUDCA demonstrate<br />

its ability to inhibit caspase activation via <strong>the</strong><br />

phosphorylation <strong>of</strong> Bad and implicate it as a<br />

potential <strong>the</strong>rapeutic agent in AAT deficiency.<br />

S Miller, C Greene,<br />

C Taggart, C McElvaney,<br />

S O’Neill<br />

Dept <strong>of</strong> Medicine,<br />

Respiratory Research<br />

Division, RCSI<br />

Education and<br />

Research Centre,<br />

Beaumont Hospital,<br />

Dublin<br />

46 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4 • SUPPLEMENT 3<br />

IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4 • SUPPLEMENT 3 47

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!